thiazolyl blue has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, GH; Li, YY; Wan, J; Wang, C; Yang, LY; Zhou, XJ | 1 |
1 other study(ies) available for thiazolyl blue and vasoactive intestinal peptide
| Article | Year |
|---|---|
Effect of vasoactive intestinal peptide (VIP) on NKG2D signal pathway and its contribution to immune escape of MKN45 cells.
Topics: Analysis of Variance; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; DNA Primers; Humans; Immunohistochemistry; Killer Cells, Natural; NF-kappa B; NK Cell Lectin-Like Receptor Subfamily K; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles; Tumor Escape; Vasoactive Intestinal Peptide | 2013 |